wednesday 9 march - European Society of Gene and Cell Therapy

WEDNESDAY 9 MARCH JOURNEE PUBLIQUE 09:15 Matinée portes ouvertes pour les enfants des écoles de Marseille (Ecole de l’ADN) 12:30-­‐
and Lunch 12:30 Posters Déjeuner 14:00 14:00 Après midi pour les patients et association de patients Introduction: Ali Saib Film: Dr Virus et Mr Hyde, TABLE RONDE Après midi ON FOCUS Inv01 Comment passer en clinique avec un vecteur? Nathalie Cartier, Anne Galy Inv02 Big Data, Traitement de données, Philippe Hupé Inv03 Microbiot (INRA) Philippe Langella Inv04 Etat des lieux, Nicolas Boisgerault 16:30 Pause Café 17:00 Keynote. Chair: Pierre Cordelier Inv05 Introduction Pierre Cordelier, Inserm U1037, University of Toulouse Inv06 Keynote speaker Nicolas Levy, Fondation Maladies Rares Inv07 Keynote speaker Mark Kay, Stanford University 18:30 Gala Evening THURSDAY 10 MARCH 08:30 Inv08 Keynote speaker Martin Fussenegger, ETH Zurich 09:15 1. Gene editing Chair: Els Verhoeyen Inv09TBC Inv10 TBC Inv11TBC Abstract 1, Abstract 2 Pietro Genovese, TIGET Tuan Nguyen, Université de Nantes Linda Popplewell, 10:30-­‐
Coffee Break 11:00 10:30 Break modelling with iPS 2. Disease 11:00 Coffee Chair: Michel Pucéat Inv12 TBC Chris Denning, University of Nottingham Inv13 Limitation to go to clinic Angel Raya, Inv14 TBC Azel Zine, Marseille Abstract 1, Abstract 2 13:00 Lunch and Posters 14:30 3. Cancer Therapy Chair: Pierre Cordelier Inv15 Virotherapy; Clinical Trial update in Oncolitic Viruses Kerry Fisher Inv16 mRNA Vaccine Ugur Sahin, University of Mainz (TBC) Inv17 CAR TCD19 Sonia Guedan, Abstract 1, Abstract 2 16:30 Coffee Break 17:00 4. Cell and Gene mediated Immunology Chair: Federico Mingozzi Inv18 Chronic inflammation Naomi Taylor Inv19 Immunology Eric Vivier, University of Marseille Inv20 Federico Mingozzi, Généthon Abstract 1, Abstract 2 20:00 Diner des speakers (Fonfon) FRIDAY 11 MARCH 09:00 5a. Recent advances in Vector developement Chair: Inv21TBC Axel Schambach Inv22 TBC Daniel Anderson, MIT Inv23 Bionspired delivery systems for RNA medicines and DNA vaccines Bruno Pitard, inCellArt Abstract 1 Abstract 2 5b. Manufacturing Chair: Inv24TBC Boro Dropulic Inv25 TBC Matthias Hebben Inv26TBC Emmanuel Martinod or Adrien Six Abstract 1 Abstract 2 11:00 Coffee Break 10:30 Break Therapies 6. Innovative 11:30 Coffee Chair: Inv27 TBC Elvire Gouze Inv28 TBC Manfred Schmitt Inv29 Tricyclo-­‐DNA: promising antisense oligonucleotides for splice-­‐switching therapy Aurélie Goyenvale Abstract 1 Abstract 2 13:30 Lunch and Posters 14:30 3. Awards and Closing Chair: Pierre Cordelier Inv27 SFTCG Award Inv28 Closing keynote 16:00 Congress ending Takanori Takebe